Palmieri L

ORCID: 0000-0002-9704-3300 · 2 papers in corpus
other 2024
Facts, views & vision in ObGyn ·doi:10.52054/fvvo.16.4.052

BACKGROUND: In 2022, OpenAI launched ChatGPT 3.5, which is now widely used in medical education, training, and research. Despite its valuable use for the generation of information, concerns persist about its authenticity and accuracy. Its u…

case-report 2024
Journal of personalized medicine ·doi:10.3390/jpm14101052

BACKGROUND: Most patients with ovarian cancer relapse within 2 years. Prospective randomized trials, such as DESKTOP III and SOC-I, have shown the role of secondary cytoreduction in improving oncological outcomes in selected patients, when …